Prospective study demonstrates feasibility of non-invasive stool collection in gynecologic oncology, indicating potential for wider use.
Non-invasive stool biospecimen collection was feasible in ambulatory gynecologic oncology practice. Provider engagement meaningfully influenced participation in stool kit collection. Stool kit return remained a key attrition point after initial patient acceptance.
No takes yet. Share an insight, caveat, or question.
Chalif et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: